GSK launches £2bn share buyback and upgrades sales forecast

3 days ago · Strong growth in HIV, oncology and specialty medicines have offset a 4 per cent decline in vaccine sales

CouponFollow Extension

£2
OFF

GSK Launches £2bn Share Buyback And Upgrades Sales Forecast

2 weeks from now

3 days ago · Strong growth in HIV, oncology and specialty medicines have offset a 4 per cent decline in vaccine sales

thetimes.com

£2
OFF

GSK Launches £2bn Buyback On Strong HIV And Cancer Drugs Sales

2 weeks from now

3 days ago · UK pharma group raises long-term annual sales forecast to over £40bn by 2031 ... GSK launches £2bn buyback on strong HIV and cancer ... Shares in GSK have fallen 12 per …

ft.com

1%
OFF

GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion …

2 weeks from now

3 days ago · Wednesday, GSK Plc (NYSE:GSK) reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and up 4% on constant currency. The …

yahoo.com

$2
OFF

GSK Launches $2.5 Billion Buyback, Lifts Sales Target After Stellar ...

2 weeks from now

3 days ago · GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and …

reuters.com

$2
OFF

GSK Lifts Long-Term Outlook On Drug Pipeline, Buys Back Shares

2 weeks from now

3 days ago · (Bloomberg) -- GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline.Most Read from …

yahoo.com

14%
OFF

GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 ... - Benzinga

2 weeks from now

3 days ago · GSK's Q4 sales hit $10.40 billion, topping estimates. Specialty Medicines grew 14%, while vaccines declined. The company announced a $2.5 billion share buyback plan.

benzinga.com

6%
OFF

GSK Shares Jump 6% As Firm Raises Sales Target, Boosts Dividends

2 weeks from now

3 days ago · GSK shares jumped 5.9% as it lifted its 2031 sales target to over £40 billion. The company plans a £2 billion share buyback over the next 18 months. GSK reported that its total …

invezz.com

$2
OFF

GSK Issues $2.5 Billion Buyback, Raises Midterm Outlook After …

2 weeks from now

3 days ago · GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. The British pharmaceutical giant said Wednesday that …

morningstar.com

$2
OFF

GSK Announces £2 Billion Share Buyback As Profit Beats Estimates

2 weeks from now

3 days ago · GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline.. The British drugmaker boosted its 2031 …

bloomberg.com

$2
OFF

GSK Ups Five-year Sales Outlook, Unveils $2bn Buyback

2 weeks from now

3 days ago · GSK's annual revenues were held back weak vaccines sales, but shares in the pharma giant jumped on Wednesday after the company unveiled plans to buy back £2bn of …

sharecast.com

5%
OFF

GSK: Enters 2025 In Good Health, Launches £2bn Buyback

2 weeks from now

3 days ago · A £2bn share buyback programme has also been launched. GSK expects top line growth of 3-5% this year and an uplift in underlying operating profit of 6-8%. The shares were …

hl.co.uk

38%
OFF

GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook

2 weeks from now

3 days ago · GSK GSK6.38%increase; green up pointing triangle plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. The …

wsj.com

$2
OFF

GSK Launches $2.5 Bln Buyback, Lifts Sales Target After Stellar Q4

2 weeks from now

3 days ago · GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and …

indiatimes.com

$2
OFF

GSK Launches $2.5 Billion Buyback, Lifts Sales Target After ... - MSN

2 weeks from now

By Yadarisa Shabong (Reuters) -GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales …

msn.com

$3
OFF

GSK Plans £2 Billion Share Buyback, Boosts Long-term Outlook

2 weeks from now

3 days ago · GSK plans to buy back £2 billion (S$3.4 billion) of shares as it raised its long-term growth outlook on optimism around its drug pipeline. The British drugmaker boosted its 2031 …

businesstimes.com.sg

$2
OFF

GSK Launches $2.5 Billion Buyback, Raises Midterm Sales Outlook

2 weeks from now

3 days ago · GSK plans to buy back $2.50 billion in shares and raised its midterm sales target, citing promising pipeline developments. The British pharmaceutical company said Wednesday …

marketscreener.com

FAQs about GSK launches £2bn share buyback and upgrades sales forecast Coupon?

Will GSK buy back £2 billion?

(Bloomberg) -- GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around the drug pipeline. Most Read from Bloomberg The British drugmaker boosted its 2031 sales forecast to over £40 billion, up from the more than £38 billion it previously expected. ...

Will GSK increase its sales?

By Yadarisa Shabong (Reuters) -GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 billion, betting that growing sales of its HIV and cancer drugs will make up for pressures on its vaccines revenue. ...

What happened to GSK shares in 2031?

GSK shares jumped 5.9% as it lifted its 2031 sales target to over £40 billion. The company plans a £2 billion share buyback over the next 18 months. GSK reported that its total sales grew by 3% in 2024, reaching £31.4 billion. Follow Invezz on Telegram, Twitter, and Google News for instant updates > ...

Why did GSK boost its 2031 sales forecast?

The British drugmaker boosted its 2031 sales forecast to over £40 billion, up from the more than £38 billion it previously expected. GSK said this reflected progress in late stage drug development, including several oncology medicines. ...

What was GSK's fourth-quarter sales?

Wednesday, GSK Plc (NYSE: GSK) reported fourth-quarter sales of $10.40 billion (8.12 billion Sterling Pounds), up 1% year-over-year and up 4% on constant currency. The analysts estimated sales of $9.58 billion. ...

How much will GSK revenue increase in 2025?

GSK expects revenue to increase between 3% and 5% in 2025 despite forecasting vaccine sales to fall by a "low single-digit" percentage. The company lifted its 2031 sales forecast to more than 40 billion pounds, from 38 billion pounds targeted previously. ...